Home
>
National Drug Code (NDC)
>
Octreotide Acetate
Octreotide Acetate - 55390-375-10 - (Octreotide Acetate)
Drug Information of Octreotide Acetate
| Product NDC: | 55390-375 |
| Proprietary Name: | Octreotide Acetate |
| Non Proprietary Name: | Octreotide Acetate |
| Active Ingredient(s): | 100 ug/mL & nbsp; Octreotide Acetate |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Octreotide Acetate
| Product NDC: | 55390-375 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076313 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090309 |
Package Information of Octreotide Acetate
| Package NDC: | 55390-375-10 |
| Package Description: | 10 VIAL in 1 BOX (55390-375-10) > 1 mL in 1 VIAL |
NDC Information of Octreotide Acetate
| NDC Code | 55390-375-10 |
| Proprietary Name | Octreotide Acetate |
| Package Description | 10 VIAL in 1 BOX (55390-375-10) > 1 mL in 1 VIAL |
| Product NDC | 55390-375 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Octreotide Acetate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20090309 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | OCTREOTIDE ACETATE |
| Strength Number | 100 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |
